Seasonal Evaluation for Regeneron Pharmaceuticals, Inc. (REGN)
The following tables show quarterly and semi-annual reports.
In the quarterly breakdown, the first through fourth quarters correspond to spring, summer, fall, and winter, respectively.
Detailed definitions for the semi-annual periods are provided in the table headers.
| Overview | 1st Quarter Jan. - Mar. |
2nd Quarter Apr. - Jun. |
3rd Quarter Jul. - Sep. |
4th Quarter Oct. - Dec. |
|---|---|---|---|---|
| Success Rate | 70.00% | 45.00% | 75.00% | 60.00% |
| Median Return | 8.41% | -2.59% | 11.44% | 5.73% |
| Average Return | 11.72% | 12.22% | 10.23% | 15.86% |
| Maximum Gain | 110.39% | 29.29% | 51.18% | 37.28% |
| Gain Year | 2012 | 2009 | 2008 | 2025 |
| Maximum Loss | -33.60% | -24.75% | -11.37% | -32.24% |
| Loss Year | 2016 | 2008 | 2019 | 2024 |
| Based on the past 20 years (2006-2025) | ||||
| Overview | Winter Season Oct. - Mar. |
Summer Season Apr. - Sep. |
First HY Jan. - Jun. |
Second HY Jul. - Dec. |
|---|---|---|---|---|
| Success Rate | 65.00% | 60.00% | 57.50% | 67.50% |
| Median Return | 7.22% | 7.40% | 5.08% | 8.03% |
| Average Return | 13.48% | 10.94% | 11.91% | 12.43% |
| Maximum Gain | 110.39% | 51.18% | 110.39% | 51.18% |
| Gain Year | 2012 | 2008 | 2012 | 2008 |
| Maximum Loss | -33.60% | -24.75% | -33.60% | -32.24% |
| Loss Year | 2016 | 2008 | 2016 | 2024 |
| Based on the past 20 years (2006-2025) | ||||